GCP ClinPlus
Discloses China clinical operations, biometrics, regulatory and safety services, with explicit China IIT support for international developers, including cell and gene therapies. A US subsidiary and international partner network support cross-border engagement.
Corporate information
- Company entity
- GCP ClinPlus
- Headquarters / principal office
- China-based / China-origin platform ↗
- Founded
- 2003 (company operating history) ↗
- Ownership / capital status
- Not verifiedSee entity-specific disclosures; group figures are not clinical revenue
- Official corporate reference
- https://www.gcpclinplus.com/about-us/ ↗
- LinkedIn company page
- LinkedIn ↗
Profile review: 2026-11-06 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
Discloses China clinical operations, biometrics, regulatory and safety services, with explicit China IIT support for international developers, including cell and gene therapies. A US subsidiary and international partner network support cross-border engagement.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- GCP ClinPlus — Official clinical services / corporate disclosure
- GCP ClinPlus — Official clinical services / corporate disclosure